Tampa, FL, United States of America

Ariosto Siqueira Silva

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ariosto Siqueira Silva. Retrieved from https://idiyas.com/inventor/ariosto-siqueira-silva

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Ariosto Siqueira Silva

Introduction

Ariosto Siqueira Silva is a notable inventor based in Tampa, FL, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods for assessing cell viability and enhancing treatment efficacy, Silva has been instrumental in advancing cancer research.

Latest Patents

Silva holds 2 patents that showcase his innovative approaches. His latest patents include:

1. **Methods for assessing cell viability or predicting cell response to a treatment using cell movement** - This patent discloses a method for selecting a cancer treatment regimen for a subject.

2. **Method of increasing intratumoral pHe and reducing acid-mediated invasion** - This method presents a way to treat cancer or inhibit metastasis by increasing intratumoral extracellular pH. It involves administering a therapeutically effective amount of a buffer with a pKa greater than 6.1, with an advantageous embodiment having a pKa of about 7.0. Examples of buffers include NaHCO, 2-imidazole-1-yl-3-ethoxycarbonylpropionic acid (IEPA), cholamine chloride, N,N-Bis(2-hydroxyethyl)-2-aminoethanesulfonic acid (BES), N-Tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES), and 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES). The method can also include pretreatment with one or more chemotherapeutic agents.

Career Highlights

Silva is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc., where he continues to work on groundbreaking cancer research. His contributions have been pivotal in developing new treatment methodologies that aim to improve patient outcomes.

Collaborations

Silva collaborates with esteemed colleagues such as Robert J Gillies and David L Morse, enhancing the research efforts at the cancer center.

Conclusion

Ariosto Siqueira Silva's innovative patents and dedication to cancer research exemplify the vital role of inventors in advancing medical science. His work continues to inspire new approaches to cancer treatment and improve the lives of patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…